Kathleen B. Mullin, R. Croop, J. Pavlović, Linda M. Mosher, T. Smith, Jennifer Madonia, M. Lovegren, R. Lipton
{"title":"Zavegepant鼻喷雾剂急性治疗偏头痛的疗效和安全性:一项3期双盲、随机、安慰剂对照试验的结果(PL5.002)","authors":"Kathleen B. Mullin, R. Croop, J. Pavlović, Linda M. Mosher, T. Smith, Jennifer Madonia, M. Lovegren, R. Lipton","doi":"10.1212/wnl.0000000000202039","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":397438,"journal":{"name":"Tuesday, April 25","volume":"213 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy and Safety of Zavegepant Nasal Spray for the Acute Treatment of Migraine: Results of a Phase 3 Double-Blind, Randomized, Placebo Controlled Trial (PL5.002)\",\"authors\":\"Kathleen B. Mullin, R. Croop, J. Pavlović, Linda M. Mosher, T. Smith, Jennifer Madonia, M. Lovegren, R. Lipton\",\"doi\":\"10.1212/wnl.0000000000202039\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":397438,\"journal\":{\"name\":\"Tuesday, April 25\",\"volume\":\"213 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tuesday, April 25\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1212/wnl.0000000000202039\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tuesday, April 25","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1212/wnl.0000000000202039","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Efficacy and Safety of Zavegepant Nasal Spray for the Acute Treatment of Migraine: Results of a Phase 3 Double-Blind, Randomized, Placebo Controlled Trial (PL5.002)